Alto Neuroscience (ANRO) Total Liabilities (2023 - 2026)

Alto Neuroscience has reported Total Liabilities for 4 years, with the latest figure at $32.9 million in Q1 2026.

• Quarterly Total Liabilities changed 0.22% year-over-year to $32.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $32.9 million (changed 0.22% YoY) and the FY2025 annual result came in at $33.5 million, up 28.62% from the prior year.
• Total Liabilities declined to $32.9 million in Q1 2026 per ANRO's latest filing, from $33.5 million in the prior quarter.
• Over five years, Total Liabilities peaked at $35.4 million in Q3 2025 and troughed at $16.8 million in Q1 2024.
• A 4-year average of $27.3 million and a median of $29.7 million in 2024 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2025 and 2026: Total Liabilities soared 96.0% in 2025, then gained 0.22% in 2026.
• Over 4 years, Total Liabilities stood at $16.8 million in 2023, then jumped by 55.04% to $26.1 million in 2024, then rose by 28.62% to $33.5 million in 2025, then declined by 1.96% to $32.9 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $32.9 million, $33.5 million, and $35.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.